iRhythm Technologies, Inc. - IRTC Profit before interest, taxes and amortization

Graphic logo of iRhythm Technologies, Inc. (IRTC)

Increased clinic referrals and the expansion of insurance reimbursements are driving the current success of iRhythm Technologies (IRTC). The chart of cash operating profit before deductions visualizes crisis resilience, where the value of 68.75 reflects this status. iRhythm Technologies leverages AI algorithms and the precision Zio ECG patch while simultaneously implementing eco-friendly sensor recycling and reducing plastic in its packaging.

iRhythm Corp - IRTC Operating profit EBITDA (period 11/23/2025 - 11/10/2026)

iRhythm - analytical breakdowns and key metrics (IRTC)

- stock quotes and analyst forecast:
Price Performance Chart iRhythm Corp|IRTC - Consensus Target
- issuer market value details:
Market Value iRhythm|IRTC - Real Price to Acquire Entire Company
- book capitalization data:
Book Price of a Share iRhythm|IRTC - Book Capitalization|Market Value to Book Value irhythmtech.com|IRTC - Aggregate Company Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio iRhythm Technologies|IRTC - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital iRhythm Technologies, Inc.|IRTC - Company Total Debt|Debt to Book Capital iRhythm|IRTC - Company Long-Term Debts|Short-Term Debt iRhythm|Quick Liquidity Indicator irhythmtech.com
- financial results and valuation multiples details:
IRTC - Net Profit|Expected Net Income iRhythm Technologies|IRTC - Price to Earnings Ratio|Price to Future Earnings Ratio irhythmtech.com|IRTC - Price/Earnings to Growth Ratio|Company Value to EBITDA iRhythm|IRTC - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months iRhythm|IRTC - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months irhythmtech.com|IRTC - Earnings growth in current year|Net earnings per one share growth forecast for next year iRhythm Technologies
Fundamental company valuation:iRhythm Corp IRTC
Mass-produced product of iRhythm Technologies, Inc.

iRhythm Technologies' high dependence on a single heart monitoring product makes tracking actual cash flows from operating activities critically important. The current value of 68.75 reflects absolute EBITDA, measuring operating efficiency excluding financial and fiscal burdens, which allows an investor to assess business sustainability and the risk of overvaluation through the dynamics of this chart.

Who iRhythm Technologies competes with

Income before deduction of interest, taxes and amortization REGN|LNTH: Operating profit before deduction of amortization|Profit before interest, taxes and amortization mineralystx.com|HTFL (HeartFlow Corp) - Operating profit before deduction of amortization|KMTS: Company profit before taxes, interest and amortization|ESPR (Esperion Therapeutics Inc) - Operating profit EBITDA|AMRN: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Anteris Technologies Global (AVR)|Operating profit before deduction of amortization tenayatherapeutics.com TNYA|CVRx - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization MIST|CRDL: Operating profit before deduction of amortization|HeartBeam Corporation - Company profit before taxes, interest and amortization|TENX: Operating profit EBITDA|Profit before interest, taxes and amortization adagiomedical.com (ADGM)|BCDA (BioCardia) - Operating profit EBITDA|Operating profit before deduction of amortization Catheter Precision Inc (VTAK)|Operating profit EBITDA ABIO|ACST (acastipharma.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Aerovate Therapeutics AVTE|VERV: Operating profit before amortization|WINT - Profit before payment of interest, taxes and amortization